Clinical trial

Chemotherapy and Radiation Therapy in Treating Patients With HIV-Related Primary…

NCT00003261 · Centro di Riferimento Oncologico - Aviano, Other · Unknown status

Key facts

NCT number NCT00003261
Title Chemotherapy and Radiation Therapy in Treating Patients With HIV-Related Primary Central Nervous System Lymphoma
Official title Treatment of HIV-Related Primary Central Nervous System Lymphoma (HIV-PCNSL): A Phase II Trial With Neoadjuvant Chemotherapy (High-Dose Methotrexate (MTX) Plus High-Dose Zidovudine) and Radiotherapy
Lead sponsor Centro di Riferimento Oncologico - Aviano, Other
Status Unknown status
Phase Phase 2
Study type Interventional
Conditions Lymphoma
Intervention type Drug, Procedure, Radiation
Interventions methotrexate, zidovudine, neoadjuvant therapy, radiation therapy
Enrollment 14
Start date May 1, 1997
First posted Jan 27, 2003
Last update posted Sep 20, 2013
Countries Italy

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies